Alexander Moylan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexander Moylan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ian Maconochie
Paediatric Emergency Department, Imperial College Hospital NHS Healthcare Trust, London, UK
3 shared publications - Abi Faiman
Paediatric Gastroenterology Dietitian, Child Health bCentre for Paediatric Gastroenterology, Royal Free Hospital, London, UK
1 shared publication Ajmal Kader
Centre for Paediatric Gastroenterology, Royal Free Hospital, London, UK
1 shared publication- Alison Booth
York Trials Unit, Department of Health Sciences, University of York, York, UK
1 shared publication Ara Darzi
Division of Surgery, Department of Surgery and Cancer, Imperial College Healthcare National Health Service Trust, London, United Kingdom
1 shared publicationAstrid Flahault Tairraz
Paediatric Emergency Department, St Mary’s Hospital, Department of Emergency Medicine, Division of Medicine, Imperial College Healthcare National Health Service Trust, London, United Kingdom
1 shared publication
Latest Publications
- 10 June 2019
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 191 (23) , E625-E626
Demand, overcrowding and the pediatric emergency department
- 10 June 2019
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 191 (23) , E625-E626
Demand, overcrowding and the pediatric emergency department
- 1 June 2019
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 173 (6) , 597-598
Assessing the Agreement of 5 Ideal Body Weight Calculations for Selecting Medication Dosages for Children With Obesity
- 1 June 2019
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 173 (6) , 597-598
Assessing the Agreement of 5 Ideal Body Weight Calculations for Selecting Medication Dosages for Children With Obesity
- Open Access
- 8 November 2018
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Primary varicella zoster infection with tongue lesions
- 8 November 2018
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Open AccessPrimary varicella zoster infection with tongue lesions
- 1 August 2018
- Published by Elsevier in Resuscitation
- Vol. 129, 70-75
Resuscitation registers: How many active registers are there and how many collect data on paediatric cardiac arrests?
- 1 August 2018
- Published by Elsevier in Resuscitation
- Vol. 129, 70-75
Resuscitation registers: How many active registers are there and how many collect data on paediatric cardiac arrests?
- 1 March 2014
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 26 (3) , 276-281
Standard versus rapid food reintroduction after exclusive enteral nutritional therapy in paediatric Crohn’s disease
Background In paediatric Crohn’s disease (PCD), 6–8 weeks of exclusive enteral nutrition (EEN) is effective in 60–80% cases. EEN is followed by gradual food reintroduction over variable (1–5 weeks) periods. Currently, there is no recommended duration or method for food reintroduction. The rationale for slow reintroduction is unclear and may be because of concerns about food intolerance or to maintain longer remission. Aims The aims of this study were as follows: to compare relapse rates following standard and rapid reintroduction of food after EEN in PCD and to determine the duration of maintained remission in two groups of PCD patients. Materials and methods Two groups with PCD were compared: group A received standard food reintroduction over 5 weeks and group B received rapid reintroduction over 3 days. Data were collected over two consecutive time periods: group A (2005–2009) and group B (2009–2011). Only patients with a new diagnosis of PCD were included. Those with strictures and those on steroids or biologicals during EEN were excluded. The minimum duration of follow-up was 1 year. Results Group A included 20 patients and group B included 19 patients. In these groups, EEN led to clinical remission in 80% of the patients in group A and in 76% of the patients in group B. At 6 months, one-third of the patients from each group had developed relapse and a year after EEN, 50% of the patients in group A and 47% of the patients in group B developed relapse. Time to first relapse was 188 days (group A) and 136 days (group B). None of these results were statistically significant. Conclusion In PCD, rapid food reintroduction following 6-week EEN is safe and equally effective as longer food reintroduction. We propose that a rapid food reintroduction schedule be recommended as the most tolerable approach for food reintroduction. Relapse rate and duration of remission are uninfluenced by the type of food reintroduction.
- 1 March 2014
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 26 (3) , 276-281
Standard versus rapid food reintroduction after exclusive enteral nutritional therapy in paediatric Crohn’s disease
Background In paediatric Crohn’s disease (PCD), 6–8 weeks of exclusive enteral nutrition (EEN) is effective in 60–80% cases. EEN is followed by gradual food reintroduction over variable (1–5 weeks) periods. Currently, there is no recommended duration or method for food reintroduction. The rationale for slow reintroduction is unclear and may be because of concerns about food intolerance or to maintain longer remission. Aims The aims of this study were as follows: to compare relapse rates following standard and rapid reintroduction of food after EEN in PCD and to determine the duration of maintained remission in two groups of PCD patients. Materials and methods Two groups with PCD were compared: group A received standard food reintroduction over 5 weeks and group B received rapid reintroduction over 3 days. Data were collected over two consecutive time periods: group A (2005–2009) and group B (2009–2011). Only patients with a new diagnosis of PCD were included. Those with strictures and those on steroids or biologicals during EEN were excluded. The minimum duration of follow-up was 1 year. Results Group A included 20 patients and group B included 19 patients. In these groups, EEN led to clinical remission in 80% of the patients in group A and in 76% of the patients in group B. At 6 months, one-third of the patients from each group had developed relapse and a year after EEN, 50% of the patients in group A and 47% of the patients in group B developed relapse. Time to first relapse was 188 days (group A) and 136 days (group B). None of these results were statistically significant. Conclusion In PCD, rapid food reintroduction following 6-week EEN is safe and equally effective as longer food reintroduction. We propose that a rapid food reintroduction schedule be recommended as the most tolerable approach for food reintroduction. Relapse rate and duration of remission are uninfluenced by the type of food reintroduction.